Using cell-based strategies to break the link between bronchopulmonary dysplasia and the development of chronic lung disease in later life

Pulmonary Medicine

Volumn , Issue , 2013, Pages

  O'Reilly, Megan ^a   Thébaud, Bernard ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EMPHYSEMA; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HOSPITAL READMISSION; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG DYSPLASIA; LUNG FUNCTION; LUNG INJURY; LUNG MINUTE VOLUME; MAXIMAL OXYGEN CONSUMPTION; MESENCHYMAL STEM CELL TRANSPLANTATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; REDUCED MAXIMAL MINUTE VENTILATION; RESIDUAL VOLUME; RESPIRATORY DISTRESS; REVIEW; SENILE EMPHYSEMA; WHEEZING;

EID: 84876509611     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2013/874161     Document Type: Review

References (78)

1. Harding R., Maritz G., Maternal and fetal origins of lung disease in adulthood. Seminars in Fetal & Neonatal Medicine 2012 17 67 72
2. Wong P. M., Lees A. N., Louw J., Lee F. Y., French N., Gain K., Murray C. P., Wilson A., Chambers D. C., Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. European Respiratory Journal 2008 32 2 321 328 2-s2.0-56149090822 10.1183/09031936.00127107
3. Bourbon J. R., Boucherat O., Boczkowski J., Crestani B., Delacourt C., Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets. Trends in Molecular Medicine 2009 15 4 169 179 2-s2.0-63649153941 10.1016/j.molmed.2009.02.003
4. Warburton D., Tefft D., Mailleux A., Bellusci S., Thiery J. P., Zhao J., Buckley S., Shi W., Driscoll B., Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny? American Journal of Respiratory and Critical Care Medicine 2001 164 10 S59 S62 2-s2.0-0035891748
5. Joss-Moore L. A., Albertine K. H., Lane R. H., Epigenetics and the developmental origins of lung disease. Molecular Genetics and Metabolism 2011 104 61 66
6. Kinsella J. P., Greenough A., Abman S. H., Bronchopulmonary dysplasia. Lancet 2006 367 9520 1421 1431 2-s2.0-33646137788 10.1016/S0140-6736(06)68615-7
7. Schulzke S. M., Pillow J. J., The management of evolving bronchopulmonary dysplasia. Paediatric Respiratory Reviews 2010 11 3 143 148 2-s2.0-77955413380 10.1016/j.prrv.2009.12.005
8. Henderson-Smart D. J., Hutchinson J. L., Donoghue D. A., Evans N. J., Simpson J. M., Wright I., Prenatal predictors of chronic lung disease in very preterm infants. Archives of Disease in Childhood: Fetal and Neonatal Edition 2006 91 1 F40 F45 2-s2.0-30344475500 10.1136/adc.2005.072264 (Pubitemid 43059201)
9. Ralser E., Mueller W., Haberland C., Rehospitalization in the first 2 years of life in children born preterm. Acta Paediatrica 2012 101 1 e1 e5
10. Friedrich L., Pitrez P. M. C., Stein R. T., Goldani M., Tepper R., Jones M. H., Growth rate of lung function in healthy preterm infants. American Journal of Respiratory and Critical Care Medicine 2007 176 12 1269 1273 2-s2.0-37149015384 10.1164/rccm.200703-476OC (Pubitemid 350256481)
11. Hjalmarson O., Sandberg K., Abnormal lung function in healthy preterm infants. American Journal of Respiratory and Critical Care Medicine 2002 165 1 83 87 2-s2.0-0036140830 (Pubitemid 34053362)
12. Friedrich L., Stein R. T., Pitrez P. M. C., Corso A. L., Jones M. H., Reduced lung function in healthy preterm infants in the first months of life. American Journal of Respiratory and Critical Care Medicine 2006 173 4 442 447 2-s2.0-32444440308 10.1164/rccm.200503-444OC (Pubitemid 43228333)
13. Gross S. J., Iannuzzi D. M., Kveselis D. A., Anbar R. D., Effect of preterm birth on pulmonary function at school age: A prospective controlled study. Journal of Pediatrics 1998 133 2 188 192 2-s2.0-0031927512 (Pubitemid 28385193)
14. Robin B., Kim Y. J., Huth J., Klocksieben J., Torres M., Tepper R. S., Castile R. G., Solway J., Hershenson M. B., Goldstein-Filbrun A., Pulmonary Function in Bronchopulmonary Dysplasia. Pediatric Pulmonology 2004 37 3 236 242 2-s2.0-12144285856 10.1002/ppul.10424 (Pubitemid 38326373)
15. Tepper R. S., Morgan W. J., Cota K., Taussig L. M., Expiratory flow limitation in infants with bronchopulmonary dysplasia. Journal of Pediatrics 1986 109 6 1040 1046 2-s2.0-0022978770 (Pubitemid 17186502)
16. Balinotti J. E., Chakr V. C., Tiller C., Kimmel R., Coates C., Kisling J., Yu Z., Nguyen J., Tepper R. S., Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. American Journal of Respiratory and Critical Care Medicine 2010 181 10 1093 1097 2-s2.0-77953236618 10.1164/rccm.200908-1190OC
17. Narang I., Review series: what goes around, comes around: childhood influences on later lung health? Long-term follow-up of infants with lung disease of prematurity. Chronic Respiratory Disease 2010 7 259 269
18. Fawke J., Lum S., Kirkby J., Hennessy E., Marlow N., Rowell V., Thomas S., Stocks J., Lung function and respiratory symptoms at 11 years in children born extremely preterm: The EPICure study. American Journal of Respiratory and Critical Care Medicine 2010 182 2 237 245 2-s2.0-77956625931 10.1164/rccm.200912-1806OC
19. Doyle L. W., Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992. Pediatric Pulmonology 2006 41 6 570 576 2-s2.0-33744496278 10.1002/ppul.20412 (Pubitemid 43801027)
20. Broström E. B., Thunqvist P., Adenfelt G., Borling E., Katz-Salamon M., Obstructive lung disease in children with mild to severe BPD. Respiratory Medicine 2010 104 3 362 370 2-s2.0-76649131555 10.1016/j.rmed.2009.10.008
21. Smith L. J., Van Asperen P. P., McKay K. O., Selvadurai H., Fitzgerald D. A., Reduced exercise capacity in children born very preterm. Pediatrics 2008 122 2 e287 e293 2-s2.0-49849095032 10.1542/peds.2007-3657
22. Welsh L., Kirkby J., Lum S., Odendaal D., Marlow N., Derrick G., Stocks J., The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax 2010 65 2 165 171 2-s2.0-76549097931 10.1136/thx.2008.107474
23. Santuz P., Baraldi E., Zaramella P., Filippone M., Zacchello F., Factors limiting exercise performance in long-term survivors of bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine 1995 152 4 1284 1289 2-s2.0-0029081282
24. Bolton C. E., Stocks J., Hennessy E., The EPICure Study: Association between hemodynamics and lung function at 11 years after extremely preterm birth. Journal of Pediatrics 2012 161 4 595 601
25. Clemm H., Roksund O., Thorsen E., Eide G. E., Markestad T., Halvorsen T., Aerobic capacity and exercise performance in young people born extremely preterm. Pediatrics 2012 129 e97 e105
26. Hacking D. F., Gibson A. M., Robertson C., Doyle L. W., Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatric Pulmonology. In press
27. Kaplan E., Yishay E. B., Prais D., Encouraging pulmonary outcome for surviving, neurologically intact extremely premature infants in the post surfactant era. Chest 2012 142 3 725 733
28. Korhonen P., Laitinen J., Hyödynmaa E., Tammela O., Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era. Acta Paediatrica 2004 93 3 316 321 2-s2.0-1542313818 10.1080/08035250410023593 (Pubitemid 38316552)
29. Kotecha S. J., Watkins W. J., Paranjothy S., Dunstan F. D., Henderson A. J., Kotecha S., Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents. Thorax 2012 67 54 61
30. Kulasekaran K., Gray P. H., Masters B., Chronic lung disease of prematurity and respiratory outcome at eight years of age. Journal of Paediatrics and Child Health 2007 43 1-2 44 48 2-s2.0-33845741020 10.1111/j.1440-1754.2007.01001.x (Pubitemid 44973401)
31. Mai X. M., Gäddlin P. O., Nilsson L., Finnström O., Björkstén B., Jenmalm M. C., Leijon I., Asthma, lung function and allergy in 12-year-old children with very low birth weight: a prospective study. Pediatric Allergy and Immunology 2003 14 3 184 192 2-s2.0-0037495986 10.1034/j.1399-3038.2003.00045.x (Pubitemid 36713377)
32. Halvorsen T., Skadberg B. T., Eide G. E., Røksund O. D., Carlsen K. H., Bakke P., Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatrica, International Journal of Paediatrics 2004 93 10 1294 1300 2-s2.0-4644263800 10.1080/08035250410028101 (Pubitemid 39273899)
33. Doyle L. W., Faber B., Callanan C., Freezer N., Ford G. W., Davis N. M., Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006 118 1 108 113 2-s2.0-33746812320 10.1542/peds.2005-2522 (Pubitemid 46071153)
34. Narang I., Rosenthal M., Cremonesini D., Silverman M., Bush A., Longitudinal evaluation of airway function 21 years after preterm birth. American Journal of Respiratory and Critical Care Medicine 2008 178 1 74 80 2-s2.0-46349100259 10.1164/rccm.200705-701OC (Pubitemid 351919195)
35. Vrijlandt E. J. L. E., Gerritsen J., Boezen H. M., Grevink R. G., Duiverman E. J., Lung function and exercise capacity in young adults born prematurely. American Journal of Respiratory and Critical Care Medicine 2006 173 8 890 896 2-s2.0-33646358955 10.1164/rccm.200507-1140OC
36. Filippone M., Bonetto G., Corradi M., Frigo A. C., Baraldi E., Evidence of unexpected oxidative stress in airways of adolescents born very preterm. European Respiratory Journal 2012 40 5 1253 1259
37. Aukland S. M., Rosendahl K., Owens C. M., Fosse K. R., Eide G. E., Halvorsen, Neonatal bronchopulmonary dysplasia predicts abnormal pulmonary HRCT scans in long-term survivors of extreme preterm birth. Thorax 2009 64 5 405 410 2-s2.0-66049120576 10.1136/thx.2008.103739
38. Sharma G., Goodwin J., Effect of aging on respiratory system physiology and immunology. Clinical interventions in aging 2006 1 3 253 260 2-s2.0-38449106142 10.2147/ciia.2006.1.3.253
39. Wang L., Green F. H. Y., Smiley-Jewell S. M., Pinkerton K. E., Susceptibility of the aging lung to environmental injury. Seminars in Respiratory and Critical Care Medicine 2010 31 5 539 553 2-s2.0-77958123299 10.1055/s-0030-1265895
40. Pinkerton K. E., Green F. H. Y., Harding R., Pinkerton K. E., Plopper C. G., Normal Aging of the Lung. The Lung: Development, Aging and the Environment 2004 London, UK Elsevier 213 233
41. Meyer K. C., Aging. Proceedings of the American Thoracic Society 2005 2 433 439 (Pubitemid 43128039)
42. Meyer K. C., Ershler W., Rosenthal N. S., Lu X. G., Peterson K., Immune dysregulation in the aging human lung. American Journal of Respiratory and Critical Care Medicine 1996 153 3 1072 1079 2-s2.0-0029880176 (Pubitemid 26081662)
43. Filippone M., Baraldi E., On early life risk factors for COPD. American Journal of Respiratory and Critical Care Medicine 2011 183 3 415 416 2-s2.0-79551548971
44. Jobe A. H., The new bronchopulmonary dysplasia. Current Opinion in Pediatrics 2011 23 2 167 172 2-s2.0-79953886949 10.1097/MOP.0b013e3283423e6b
45. Agostini C., Stem cell therapy for chronic lung diseases: hope and reality. Respiratory Medicine 2010 104 1 S86 S91 2-s2.0-77953025562 10.1016/j.rmed.2010.03.022
46. Blaisdell C. J., Gail D. B., Nabel E. G., National heart, lung, and blood institute perspective: lung progenitor and stem cells-gaps in knowledge and future opportunities. Stem Cells 2009 27 9 2263 2270 2-s2.0-70349871249 10.1002/stem.148
47. Sueblinvong V., Weiss D. J., Stem cells and cell therapy approaches in lung biology and diseases. Translational Research 2010 156 3 188 205 2-s2.0-77956241957 10.1016/j.trsl.2010.06.007
48. Van Haaften T., Byrne R., Bonnet S., Rochefort G. Y., Akabutu J., Bouchentouf M., Rey-Parra G. J., Galipeau J., Haromy A., Eaton F., Chen M., Hashimoto K., Abley D., Korbutt G., Archer S. L., Thébaud B., Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. American Journal of Respiratory and Critical Care Medicine 2009 180 11 1131 1142 2-s2.0-70449671455 10.1164/rccm.200902-0179OC
49. Baker C. D., Ryan S. L., Ingram D. A., Seedorf G. J., Abman S. H., Balasubramaniam V., Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. American Journal of Respiratory and Critical Care Medicine 2009 180 5 454 461 2-s2.0-69249083260 10.1164/rccm.200901-0115OC
50. Borghesi A., Massa M., Campanelli R., Bollani L., Tzialla C., Figar T. A., Ferrari G., Bonetti E., Chiesa G., De Silvestri A., Spinillo A., Rosti V., Stronati M., Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine 2009 180 6 540 546 2-s2.0-69949110938 10.1164/rccm.200812-1949OC
51. Liu X., Xie C., Human endothelial progenitor cells isolated from COPD patients are dysfunctional. Molecular and Cellular Biochemistry 2012 363 53 63
52. Timmermans F., Plum J., Yöder M. C., Ingram D. A., Vandekerckhove B., Case J., Endothelial progenitor cells: identity defined? Journal of Cellular and Molecular Medicine 2009 13 1 87 102 2-s2.0-58649108952 10.1111/j.1582-4934. 2008.00598.x
53. Kim E. K., Lee J. H., Jeong H. C., Impaired colony-forming capacity of circulating endothelial progenitor cells in patients with emphysema. The Tohoku Journal of Experimental Medicine 2012 227 321 331
54. Aslam M., Baveja R., Liang O. D., Fernandez-Gonzalez A., Lee C., Mitsialis S. A., Kourembanas S., Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. American Journal of Respiratory and Critical Care Medicine 2009 180 11 1122 1130 2-s2.0-70449686885 10.1164/rccm.200902-0242OC
55. Tropea K. A., Leder E., Aslam M., Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. American Journal of Physiology 2012 302 L829 L837
56. Zhang X., Wang H., Shi Y., The role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biology International 2012 36 589 594
57. Hansmann G., Fernandez-Gonzalez A., Aslam M., Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulmonary Circulation 2012 2 170 181
58. Pierro M., Ionescu L., Montemurro T., Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax. In press
59. Chang Y. S., Choi S. J., Sung D. K., Intratracheal transplantation of human umbilical cord blood derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplantation 2011 20 1843 1854
60. Chang Y. S., Oh W., Choi S. J., Sung D. K., Kim S. Y., Choi E. Y., Kang S., Jin H. J., Yang Y. S., Park W. S., Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplantation 2009 18 8 869 886 2-s2.0-72049118713 10.3727/ 096368909X471189
61. Huh J. W., Kim S. Y., Lee J. H., Bone marrow cells repair cigarette smoke-induced emphysema in rats. American Journal of Physiology 2011 301 L255 L266
62. Zhen G., Liu H., Gu N., Zhang H., Xu Y., Zhang Z., Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Frontiers in Bioscience 2008 13 9 3415 3422 2-s2.0-42649127352 10.2741/2936 (Pubitemid 351594692)
63. Shigemura N., Okumura M., Mizuno S., Imanishi Y., Matsuyama A., Shiono H., Nakamura T., Sawa Y., Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. American Journal of Respiratory and Critical Care Medicine 2006 174 11 1199 1205 2-s2.0-33845538717 10.1164/rccm.200603-406OC (Pubitemid 44924820)
64. Shigemura N., Okumura M., Mizuno S., Imanishi Y., Nakamura T., Sawa Y., Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. American Journal of Transplantation 2006 6 11 2592 2600 2-s2.0-33749993448 10.1111/j.1600-6143.2006.01522.x (Pubitemid 44571679)
65. Katsha A. M., Ohkouchi S., Xin H., Kanehira M., Sun R., Nukiwa T., Saijo Y., Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Molecular Therapy 2011 19 1 196 203 2-s2.0-78650923962 10.1038/mt.2010.192
66. Kumamoto M., Nishiwaki T., Matsuo N., Kimura H., Matsushima K., Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. European Respiratory Journal 2009 34 3 740 748 2-s2.0-70349137934 10.1183/09031936.00128508
67. Moodley Y., Atienza D., Manuelpillai U., Samuel C. S., Tchongue J., Ilancheran S., Boyd R., Trounson A., Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. American Journal of Pathology 2009 175 1 303 313 2-s2.0-67649910145 10.2353/ajpath.2009.080629
68. Ortiz L. A., DuTreil M., Fattman C., Pandey A. C., Torres G., Go K., Phinney D. G., Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences of the United States of America 2007 104 26 11002 11007 2-s2.0-34547402979 10.1073/pnas.0704421104 (Pubitemid 47175216)
69. Ortiz L. A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., Phinney D. G., Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8407 8411 2-s2.0-0037478581 10.1073/pnas.1432929100 (Pubitemid 36842558)
70. Rojas M., Xu J., Woods C. R., Mora A. L., Spears W., Roman J., Brigham K. L., Bone marrow-derived mesenchymal stem cells in repair of the injured lung. American Journal of Respiratory Cell and Molecular Biology 2005 33 2 145 152 2-s2.0-24344448730 10.1165/rcmb.2004-0330OC (Pubitemid 41473051)
71. Lee J. W., Fang X., Krasnodembskaya A., Howard J. P., Matthay M. A., Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 2011 29 6 913 919 2-s2.0-79957619269 10.1002/stem.643
72. Balasubramaniam V., Ryan S. L., Seedorf G. J., Roth E. V., Heumann T. R., Yoder M. C., Ingram D. A., Hogan C. J., Markham N. E., Abman S. H., Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. American Journal of Physiology 2010 298 3 L315 L323 2-s2.0-77249157301 10.1152/ajplung.00089.2009
73. Vosdoganes P., Hodges R. J., Lim R., Westover A. J., Acharya R. Y., Wallace E. M., Moss T. J. M., Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. American Journal of Obstetrics and Gynecology 2011 205 2 156.e26 156.e33 2-s2.0-79960921035 10.1016/j.ajog.2011.03.054
74. Moodley Y., Ilancheran S., Samuel C., Vaghjiani V., Atienza D., Williams E. D., Jenkin G., Wallace E., Trounson A., Manuelpillai U., Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. American Journal of Respiratory and Critical Care Medicine 2010 182 5 643 651 2-s2.0-77957701000 10.1164/rccm.201001-0014OC
75. Murphy S., Lim R., Dickinson H., Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplantation 2011 20 909 923
76. Hegab A. E., Kubo H., Fujino N., Suzuki T., He M., Kato H., Yamaya M., Isolation and characterization of murine multipotent lung stem cells. Stem Cells and Development 2010 19 4 523 535 2-s2.0-77950626100 10.1089/scd.2009.0287
77. Wang D., Morales J. E., Calame D. G., Alcorn J. L., Wetsel R. A., Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Molecular Therapy 2010 18 3 625 634 2-s2.0-77649267885 10.1038/mt.2009.317
78. Aguilar S., Scotton C. J., McNulty K., Nye E., Stamp G., Laurent G., Bonnet D., Janes S. M., Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS ONE 2009 4 11, article e8013 2-s2.0-71049119028 10.1371/journal.pone.0008013